Jounce Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.00
|
|
Average Rating
|
4.17
|
|
# Strong Buys
|
2
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.64
|
-0.60
|
0.04
|
6.25%
|
|
2022-06-30
|
-0.68
|
-0.65
|
0.03
|
4.41%
|
|
2022-03-31
|
-0.57
|
-0.72
|
-0.15
|
-26.32%
|
|
2021-12-31
|
-0.32
|
-0.59
|
-0.27
|
-84.38%
|
|
2021-09-30
|
-0.44
|
-0.59
|
-0.15
|
-34.09%
|
|
2021-06-30
|
-0.36
|
-0.08
|
0.28
|
77.78%
|
|
2021-03-31
|
-0.41
|
-0.58
|
-0.17
|
-41.46%
|
|
2020-12-31
|
0.22
|
0.86
|
0.64
|
290.91%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.97
|
|
2021-12-31
|
-1.84
|
|
2020-12-31
|
-1.47
|
|
2019-12-31
|
1.63
|
|
2018-12-31
|
-0.83
|
|
2017-12-31
|
-0.55
|
|
2016-12-31
|
0.41
|